4//SEC Filing
KURLAND FRED 4
Accession 0001104659-19-043489
CIK 0001614067other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 9:17 PM ET
Size
5.2 KB
Accession
0001104659-19-043489
Insider Transaction Report
Form 4
KURLAND FRED
Chief Financial Officer
Transactions
- Award
Stock Options
2019-06-05+15,000→ 54,575 totalExercise: $9.03Exp: 2029-06-05→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]1/48th of the stock options vest in equal installments on the 5th calendar day of each month beginning on July 5, 2019.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001267273
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 9:17 PM ET
- Size
- 5.2 KB